Mou Peng

Also affiliated with West China Second University Hospital of Sichuan University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target”.

KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target

Science Immunology(2021)10.1126/sciimmunol.abf9792

N/A

2.5DataRank · unranked

89 citations

Xiaoxin Ren, Phillip M. Galbo, Scott Moerdler, Hao Wang, R. Alejandro Sica +11 more

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity

Journal of Clinical Investigation(2022)10.1172/jci163620

N/A

0DataRank · unranked

54 citations

Mou Peng, Xing Peng, Wei Yao, Phillip M. Galbo, Devin T. Corrigan +10 more

Functional Contribution of Cancer-Associated Fibroblasts in Glioblastoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.07.487495

N/A

0DataRank · unranked

7 citations

Yang Liu, Mou Peng, Yao Wei, Anne Tranberg Madsen, Sarah Graff +6 more

Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0493

N/A

0DataRank · unranked

63 citations

Anne Tranberg Madsen, Yang Liu, Mou Peng, Wei Yao, Michael J. Ciesielski +8 more